SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-030303
Filing Date
2023-08-28
Accepted
2023-08-28 08:10:17
Documents
14
Period of Report
2023-08-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42124
2 ex99-1.htm EX-99.1 20213
3 ex99-1_001.jpg GRAPHIC 6870
  Complete submission text file 0001493152-23-030303.txt   249887

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bmra-20230828.xsd EX-101.SCH 3018
5 XBRL LABEL FILE bmra-20230828_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE bmra-20230828_pre.xml EX-101.PRE 22361
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3199
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9493792875
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

IRS No.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-37863 | Film No.: 231210346
SIC: 2835 In Vitro & In Vivo Diagnostic Substances